<?xml version="1.0" encoding="UTF-8"?>
<ref id="b58-dic-2020-4-15">
 <label>58</label>
 <element-citation publication-type="webpage">
  <collab>US National Library of Medicine</collab>
  <source>An investigation into beneficial effects of interferon beta 1a, compared to interferon beta 1b and the base therapeutic regiment in moderate to severe COVID-19: a randomized clinical trial (DIC)</source>
  <comment>
   <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04343768?term=lopinavir&amp;cond=Covid+19&amp;draw=3&amp;rank=15" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04343768?term=lopinavir&amp;cond=Covid+19&amp;draw=3&amp;rank=15</ext-link>. Published 2020
  </comment>
  <date-in-citation>Accessed April 22, 2020</date-in-citation>
 </element-citation>
</ref>
